[Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L, Groenewald C, Coupland SE, Damato B.
Br J Ophthalmol. 2014 Jun;98(6):775-9. doi: 10.1136/bjophthalmol-2013-304501. Epub 2014 Feb 25.
[Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
Bechrakis NE, Bornfeld N, Zöller I, Foerster MH.
Ophthalmologe. 2001 Aug;98(8):736-42. doi: 10.1007/s003470170081.
Escherichia coli endophthalmitis after trans-scleral resection of uveal melanoma.
Balestrazzi A, Blasi MA, Primitivo S, Balestrazzi E.
Eur J Ophthalmol. 2002 Sep-Oct;12(5):437-9. doi: 10.1177/112067210201200517.
Indications for trans-scleral local resection of uveal melanoma.
Damato B, Foulds WS.
Br J Ophthalmol. 1996 Nov;80(11):1029-30. doi: 10.1136/bjo.80.11.1029.
Treatment of primary intraocular melanoma.
Damato B.
Expert Rev Anticancer Ther. 2006 Apr;6(4):493-506. doi: 10.1586/14737140.6.4.493.
Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.
Damato BE, Paul J, Foulds WS.
Br J Ophthalmol. 1996 Feb;80(2):102-8. doi: 10.1136/bjo.80.2.102.
Developments in the management of uveal melanoma.
Damato B.
Clin Exp Ophthalmol. 2004 Dec;32(6):639-47. doi: 10.1111/j.1442-9071.2004.00917.x.
Risk factors for metastatic uveal melanoma after trans-scleral local resection.
Damato BE, Paul J, Foulds WS.
Br J Ophthalmol. 1996 Feb;80(2):109-16. doi: 10.1136/bjo.80.2.109.
Local treatment failure after globe-conserving therapy for choroidal melanoma.
Chang MY, McCannel TA.
Br J Ophthalmol. 2013 Jul;97(7):804-11. doi: 10.1136/bjophthalmol-2012-302490. Epub 2013 May 3.
Choroidal melanoma in a 7-year-old child treated by trans-scleral local resection.
Russo A, Coupland SE, O'Keefe M, Damato BE.
Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):747-9. doi: 10.1007/s00417-009-1295-z. Epub 2010 Feb 9.
